Safeguard Scientifics, Inc.
435 Devon Park Drive
Building 800
Wayne,
PA 19087
United States - Map
Phone: 610-293-0600
Fax: 610-293-0601
Web Site: http://www.safeguard.com
| Safeguard Scientifics, Inc. is a private equity and venture capital firm specializing in expansion financing, growth capital, management buyout, recapitalization, industry consolidation, corporate spinout, and early stage financing transactions. The firm prefers to make investments in companies engaged in the technology and life sciences sectors. Within the technology sector it invests in software as a service, technology enabled services, new media, and internet-based businesses. It also invests in financial services information technology; healthcare information technology; and life sciences including molecular and point-of-care, medical devices, regenerative medicine, drug formulation and delivery technologies; molecular diagnostics; pharma services; and products, and specialty pharmaceuticals; supply chain and logistics; analytics, B2B Internet, and business intelligence; enterprise applications; and infrastructure, security, and communication. The firm invests throughout United States and Canada. It typically invests between $5 million and $50 million in portfolio companies. Specifically the firm invests between $25 million and $50 million in growth buyout financing, between $10 million and $25 million in growth equity financing, and between $5 million and $10 million in early-stage financing. The firm typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, venture capital-backed seeking a growth partner, and Micro cap public companies. It seeks primary or minority ownership in the portfolio company. The firm prefers to invest in companies having proprietary technology and intellectual property. It was formerly known as Lancaster Corporation. Safeguard Scientifics, Inc. was founded in 1953 and is based in Wayne, Pennsylvania with an additional office in Weston, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Peter J. Boni , 63
Chief Exec. Officer, Pres, Member of Board of Directors, Member of Acquisition Committee and Member of Strategy Committee |
N/A
| N/A | Mr. Stephen T. Zarrilli CPA, 48
Chief Financial Officer, Principal Accounting Officer and Sr. VP |
N/A
| N/A | Mr. Kevin L. Kemmerer , 41
Exec. VP and Managing Director of Technology Group |
$
396.00K | N/A | Mr. James A. Datin MBA, 47
Exec. VP and Managing Director of Life Sciences |
N/A
| N/A | Mr. Brian J. Sisko , 48
Sr. VP and Gen. Counsel |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.52% Nasdaq 0.00%
Profile
